AUTL vs MTTR
Autolus Therapeutics Ltd (AUTL) versus MTTR (MTTR) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
MTTR (MTTR) common stock.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
MTTR does not have a complete income-statement cache yet.
AUTL currently screens at market cap $614.8M.
Not investment advice. Open the AUTL and MTTR stock pages for the full models.
Not investment advice.